IL33 and myeloproliferative disorder: In mouse models, we found that IL-33 supports MPN-like disease and myeloproliferation in mice deficient in Inppd5 or in irradiated recipients transfused with BM cells transgenic for human JAK2V617F, one of the most common driver mutations in MPN patients (102).